Crc Handbook Of Chemotherapeutic Agents

The Seventh Edition of this pocket reference is a practical, disease-focused guide to the best current medical practice in cancer chemotherapy. In easy-to-follow outline format, the book provides complete coverage of the principles of rational chemotherapy, the chemotherapeutic and biotherapeutic agents available, the treatment of specific cancers, and selected aspects of supportive care. Emphasis is on the indications, dosage/schedule, potential toxicities, and safe administration of the drugs and their use in treating specific malignancies. This edition describes seventeen new chemotherapeutic agents, with particular attention to molecular targeted agents. Updated chapters on individual cancers and supportive care provide state-of-the-art treatment recommendations.

The Sixth Edition of this handbook is a practical, disease-focused pocket reference that emphasizes the optimal current medical practice as it relates to the delivery of chemotherapeutic drugs. In an easy-to-follow outline format, the book provides complete coverage of the basic principles of rational chemotherapy, the drugs and biologic agents available, the treatment of specific cancers, and selected aspects of supportive care. New to this edition: advances in therapies for individual cancers; significant updating of the drug information section and specific tumor types to reflect the recent development of many new agents, particularly biologic ones; and new American Cancer Society screening guidelines and cancer website information.

This handbook discusses state-of-the-art characteristics of cytotoxic reconstitution services from an international perspective. Written for pharmacists, nurses, physicians and other personnel caring for patients receiving chemotherapy, the handbook features 58 monographs on chemotherapeutic agents including cytokines, adjuvant therapies, and investigational drugs. The third edition fully updates the second edition. New sections analyze the changing context of cancer care, quality assurance in cytotoxic services, and managing complications of chemotherapy.